UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive study tracks safety of new liver cancer treatments
Disease control CompletedThis study monitored the safety of two already-approved drugs, IMJUDO and IMFINZI, in real-world patients with advanced liver cancer that cannot be removed by surgery. It involved 1200 patients in Japan to collect safety information after the drugs were made available to doctors.…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial tests new injection for Tough-to-Treat liver cancer
Disease control CompletedThis early-stage study tested the safety of an experimental injection called NRT6003 in 40 adults with liver cancer that could not be removed by surgery. The main goal was to see if the treatment was safe, while also checking if it could shrink tumors and improve patients' qualit…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New scan could give doctors clearer picture of liver cancer fight
Diagnosis CompletedThis study tested whether a new type of PET scan could improve how doctors monitor advanced liver cancer during immunotherapy. Researchers used a special radioactive tracer designed to stick to liver cancer cells to see if the scans provided a clearer picture of how the cancer wa…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC